HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
P Hersey Selected Research
P Hersey Research Topics
Disease
28
Melanoma (Melanoma, Malignant)
01/2020 - 04/2000
3
Necrosis
06/2013 - 07/2000
2
Disease Progression
01/2019 - 08/2009
1
Neoplasms (Cancer)
05/2014
1
Rupture
06/2013
1
Sarcoma (Soft Tissue Sarcoma)
06/2013
1
Neoplasm Metastasis (Metastasis)
11/2005
1
B-Cell Lymphoma (Lymphoma, B Cell)
11/2000
Drug/Important Bio-Agent (IBA)
6
Proteins (Proteins, Gene)
FDA Link
05/2014 - 08/2009
5
TNF-Related Apoptosis-Inducing Ligand
IBA
08/2010 - 04/2000
3
Small Interfering RNA (siRNA)
IBA
06/2013 - 08/2010
3
Ligands
IBA
10/2001 - 10/2000
3
Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
IBA
10/2001 - 11/2000
3
NF-kappa B (NF-kB)
IBA
05/2001 - 07/2000
2
Antibodies
IBA
01/2020 - 11/2005
2
Mitogen-Activated Protein Kinase Kinases (MEKs)
IBA
11/2016 - 05/2014
2
PLX 4720
IBA
05/2014 - 09/2010
2
Messenger RNA (mRNA)
IBA
05/2014 - 09/2010
2
Extracellular Signal-Regulated MAP Kinases (Extracellular Signal Regulated Kinases)
IBA
05/2014 - 11/2005
2
Caspases
IBA
06/2013 - 11/2000
2
Caspase 3 (Caspase-3)
IBA
06/2013 - 10/2001
2
Caspase 8 (Caspase-8)
IBA
08/2010 - 11/2000
2
DNA (Deoxyribonucleic Acid)
IBA
08/2009 - 11/2007
2
Peptides (Polypeptides)
IBA
08/2009 - 07/2008
2
Vaccines
IBA
08/2009 - 07/2008
2
Temozolomide (Temodar)
FDA Link
Generic
04/2009 - 11/2007
2
Interleukin-2 (IL2)
IBA
07/2008 - 07/2000
2
Monophenol Monooxygenase (Tyrosinase)
IBA
07/2008 - 01/2001
2
Death Domain Receptors
IBA
10/2001 - 05/2001
2
Proteasome Inhibitors
IBA
05/2001 - 03/2001
1
Programmed Cell Death 1 Receptor
IBA
01/2020
1
pembrolizumab
IBA
01/2019
1
U 0126 (UO 126)
IBA
05/2014
1
Eukaryotic Initiation Factor-4E
IBA
05/2014
1
Vemurafenib
IBA
06/2013
1
Annexin A5
IBA
06/2013
1
necrostatin-1
IBA
06/2013
1
Histone Deacetylases (Histone Deacetylase)
IBA
06/2013
1
Propidium (Propidium Iodide)
IBA
06/2013
1
Protein Kinases (Protein Kinase)
IBA
06/2013
1
Phosphoric Monoester Hydrolases (Phosphatases)
IBA
06/2012
1
Proto-Oncogene Protein c-ets-1
IBA
08/2011
1
Protein Isoforms (Isoforms)
IBA
09/2010
1
CASP8 and FADD-Like Apoptosis Regulating Protein (FLIP-S)
IBA
08/2010
1
Cystatin B
IBA
08/2010
1
Cathepsin B
IBA
08/2010
1
Cysteine Proteases (Cysteine Protease)
IBA
08/2010
1
Ubiquitin-Protein Ligases (Ubiquitin-Protein Ligase)
IBA
08/2010
1
interleukin-21 (interleukin 21)
IBA
08/2009
1
L-Lactate Dehydrogenase (Lactate Dehydrogenase)
IBA
08/2009
1
RNA (Ribonucleic Acid)
IBA
08/2009
1
Monoclonal Antibodies
IBA
08/2009
1
Sunitinib (Sutent)
FDA Link
08/2009
1
Biomarkers (Surrogate Marker)
IBA
08/2009
1
Dasatinib (BMS 354825)
FDA Link
08/2009
1
Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)
IBA
08/2009
1
Imatinib Mesylate (Gleevec)
FDA Link
08/2009
1
Apoptosis Regulatory Proteins
IBA
08/2009
1
CTLA-4 Antigen
IBA
08/2009
1
O(6)-Methylguanine-DNA Methyltransferase
IBA
04/2009
1
lomeguatrib
IBA
04/2009
1
Alkylating Agents
IBA
11/2007
1
Guanine
IBA
11/2007
1
A-Form DNA (A-DNA)
IBA
11/2007
1
Formaldehyde (Formol)
FDA Link
11/2005
1
MART-1 Antigen
IBA
11/2001
1
Antigens
IBA
11/2001
1
Poly(ADP-ribose) Polymerases (Poly ADP Ribose Polymerase)
IBA
10/2001
1
caspase-activated DNase inhibitor
IBA
10/2001
1
TNF-Related Apoptosis-Inducing Ligand Receptors
IBA
10/2001
1
Interleukin-10 (Interleukin 10)
IBA
06/2001
1
Apoferritins
IBA
06/2001
1
NF-KappaB Inhibitor alpha
IBA
05/2001
1
Cytochromes c (Cytochrome c)
IBA
11/2000
1
Caspase 9
IBA
11/2000
1
Fas Ligand Protein (Fas Ligand)
IBA
11/2000
1
Matrix Metalloproteinases (MMPs)
IBA
11/2000
1
Effector Caspases
IBA
11/2000
1
Cytokines
IBA
07/2000
1
Complementary DNA (cDNA)
IBA
04/2000
Therapy/Procedure
4
Therapeutics
01/2020 - 07/2000
3
Immunotherapy
08/2009 - 07/2000
2
Drug Therapy (Chemotherapy)
08/2009 - 11/2001
1
Withholding Treatment
01/2020
1
Immunomodulation
08/2009